Challenges and opportunities in live biotherapeutic products development

Currently, some drugs for certain diseases have shown some disadvantages, including inadequate efficacy, hypersensitivity and resistance, side effects caused by long-term use, and high cost. In the face of this situation. LBPs provide a new approach to drug development, with specificity, targeting, and safety advantages providing broad application prospects in a variety of disease types.